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Alcohol and Cigarette Smoke Decrease Lung Epithelial Cell Proliferation
D. L. Jordan, D. D. Mosley, C. A. Ochoa, C. G. Nissen, C. D. Bauer, A. J. Heires, D. J. Romberger, and  T. A. Wyatt
Dept of Internal Medicine, Pulmonary Division, University of Nebraska Medical Center, Omaha, NE 68198
\
HYPOTHESIS
We hypothesize that cigarette smoke, alcohol, and the combination of the two will negatively 
impact epithelial cell proliferation on lung scaffolds. In the presence of ADX-102 , we hypothesize 





1. Alcohol and cigarette smoke can slow the proliferation of bronchial epithelial cells on a lung scaffold.
2. Cells lacking Protein kinase C epsilon do not significantly respond to smoke and alcohol with this 
injury to proliferation.
3. The aldehyde trapping drug, ADX-102, appears to have a potential protective role in cell proliferation 
by preventing smoke and alcohol activated PKC epsilon.
4. ADX-102 may have future potential therapeutic applications to lung injury and repair.
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Figure 1. 16 HBE WT cells that were treated 
with CSE and EtOH show a significant decrease 
in cell proliferation. ***P<0.0006 vs media.
Figure 2. 16 HBE DN cells (lacking PKCε
activity) treated with CSE and EtOH show no 
significant decrease in cell proliferation.
Figure 3. 16 HBE WT cells pre-treated with 
ADX-102 show a non-significant trend toward 




Significance of Alcohol Studies. In 2019, 14.5 million people ages 12 and older had an 
alcohol use disorder (AUD).  Approximately  95,000 people die from alcohol-related causes 
annually. In 2010, alcohol misuse cost the United States $249.0 billion. 4
Polysubstance Misuse. >80% of persons with AUD also smoke. Nicotine dependence is more 
severe in smokers with a history of alcohol dependence. 3
The Role of Alcohol in Lung Disease and Chronic Obstructive Pulmonary Disease
(COPD) is Often Overlooked.
Effects of Smoke and Alcohol. The presence of cigarette smoke and alcohol in the lung
leads to the build-up of reactive aldehydes, namely, malondialdehyde and acetaldehyde.
One known consequence of aldehydes in smoke and alcohol co-exposure is the activation
of Protein Kinase C epsilon. Activation of this enzyme can cause cilia slowing and
increased inflammatory cytokine release.
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Figure 4. Primary ciliated mouse tracheal 
epithelial cells (MTEC) pre-treated with ADX-102 
show no changes in PKCε activity in response to 






16 HBE wild type cells and cells expressing a dominant negative PKCε were cultured in DMEM 
with 10% serum. Cells were maintained in culture at 37°C. Primary mouse tracheal epithelial 
cells (MTEC) were grown on air-liquid interface for full differentiation.
Cigarette Smoke Extract.
Cigarette smoke was extracted as previously described1
using 1R6F reference cigarettes. One 85mm research 
grade unfiltered cigarette prepares 25mL of CSE solution 
(100%) in serum-free medium. Solution is filter-sterilized 
and diluted to desired target concentration (5%).
Viability Assay.
Cell viability was determined by 
lactate dehydrogenase (LDH) 
release using a commercial kit 
(Sigma). No loss of cell viability 
was determined under smoke and 
alcohol treatments.
Proliferation Assay.
After duration of the growth period, proliferation was assayed 
using the MTT Assay to determine cell growth using the 
protocol previously described2
ADX Treatment.
ADX-102 (Reproxalap) is a novel inhibitor of reactive 
aldehyde species. This drug acts as an aldehyde 
trapping/scavenging drug. Following the protocol 
above, 16 HBE WT cells were seeded onto lung 
scaffolds then pretreated with or without 10 µM ADX-
102 for 1 hr. Cells were then allowed to proliferate for 
4 days and exposed to media, 5% CSE, 100 mM 
EtOH, or the combination of both CSE and EtOH).
Seeding Protocol on Lung Scaffolds.
Three different lung scaffolding types were used in 
this experiment. These scaffoldings were obtained 
from different human donors and were allowed to 
equilibrate in a 37°C incubator overnight. After 
equilibration of scaffolds, cells were seeded at 1×105
per scaffold and allowed to adhere onto scaffolds 
overnight in a 37°C incubator as previously outlined2. 
Scaffold Proliferation Protocol.
Cells were allowed to proliferate across lung scaffolds for 6 days. Cells were treated with the 
appropriate treatment group every day for the duration of the growth period. The cells were 
exposed to one of the following treatment groups: media control, 5% CSE, 100mM EtOH, 
and a combination of the CSE and EtOH.
